Mellozzan 0
Mellozzan 0 is a medicine authorised by Swissmedic under authorisation number 69463. The authorisation holder is Salmon Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 11 June 2024 and the authorisation is limited until 10 June 2029. ATC code N05CH01 places the medicine in the group Psycholeptics.
| Authorisation number | 69463 |
|---|---|
| Name | Mellozzan 0 |
| Full name | Mellozzan 0,5 mg, Tabletten |
| Authorisation holder | Salmon Pharma GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N05CH01 |
| First authorisation | 11 June 2024 |
| Authorisation validity | 10 June 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Mellozzan 0,5 mg, Tabletten | B | 11 June 2024 |
| 2 | Mellozzan 1 mg, Tabletten | B | 11 June 2024 |
| 3 | Mellozzan 2 mg, Tabletten | B | 11 June 2024 |
| 4 | Mellozzan 3 mg, Tabletten | B | 11 June 2024 |
| 5 | Mellozzan 4 mg, Tabletten | B | 11 June 2024 |
| 6 | Mellozzan 5 mg, Tabletten | B | 11 June 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 100 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 7 | 30 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 13 | 30 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 19 | 60 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 2 | 100 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 8 | 30 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 14 | 30 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 20 | 60 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 3 | 100 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 9 | 30 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 15 | 30 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 21 | 60 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 4 | 100 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 10 | 30 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 16 | 30 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 22 | 60 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 5 | 100 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 11 | 30 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 17 | 30 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 23 | 60 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 6 | 100 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 12 | 30 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 18 | 30 | Tablette(n) | N05CH01 | 01.03.1. | B |
| 24 | 60 | Tablette(n) | N05CH01 | 01.03.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Mellozzan 0 authorised in Switzerland?
Yes. Mellozzan 0 is authorised by Swissmedic under authorisation number 69463, data as of 01 September 2026. The authorisation is limited until 10 June 2029.
Which dispensing category does Mellozzan 0 have?
Mellozzan 0 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Mellozzan 0?
The authorisation holder is Salmon Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.